Abstract
Retro-Prospective Observational Study on the Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia (CML) Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR-PRO)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have